We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Recovery room

24 October 2016 By Dominic Elliott

The $27-billion Dutch healthcare technology company grew core sales 5 percent in the third quarter. Reductions in costly long-term debt will help earnings, but a full recovery hinges on Philips selling more of its weaker lighting business and a rise in European medical spending.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)